techMARK (TASX)

(Sharecast News) - RBC Capital Markets initiated coverage of BAE Systems on Tuesday at 'sector perform' with a 2,200p price target, as it highlighted steady growth but slightly below peers.

• Read full story

(Sharecast News) - Shares in Oxford Biomedica tanked by a quarter on Friday after the cell and gene therapy manufacturer slashed its full year revenue and margins forecast citing short‑term client ordering delays, programme deferrals and operational delays at its North Carolina facility.

• Read full story

(Sharecast News) - Medical equipment manufacturer Smith & Nephew posted improved first‑half revenue and operating profits on Tuesday but trimmed its full‑year revenue growth outlook, saying it now expects around 4% growth rather than the 6% previously guided.

• Read full story

BAE Systems upgrades full-year guidance as H1 pr...	30-Jul-2026
Sage reiterates full-year outlook as revenue grows	29-Jul-2026
GSK launches £2bn cost savings drive, confirms ...	28-Jul-2026
Ofcom proposes blocking new Openreach discount s...	28-Jul-2026
Vodafone sees earnings at top end after strong Q1	27-Jul-2026
Renishaw to beat own guidance after record fourt...	24-Jul-2026
BT makes 'solid start' to FY27, adjusted revenue...	23-Jul-2026
Dialight sees FY profit ahead of its expectations	22-Jul-2026
Berenberg upgrades Computacenter to 'buy'	20-Jul-2026
GSK secures EMA review for single‑dose Bex...	20-Jul-2026
GSK shares fall as cough drug development axed	17-Jul-2026
Oxford Biomedica inks service deal with Plowshar...	16-Jul-2026
QinetiQ trades as expected in first quarter	16-Jul-2026
Genus sees FY 'moderately ahead' of expectations...	14-Jul-2026
Berenberg reiterates 'buy' rating on Genus	14-Jul-2026
GSK rectal cancer drug shows positive result in ...	13-Jul-2026
GSK hails 'milestone' drug trial results in China	10-Jul-2026